Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder

Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis

(2017) Nalan Nese et al.   Journal of the National Comprehensive Cancer Network

p16INK4aExpression Analysis as an Ancillary Tool for Cytologic Diagnosis of Urothelial Carcinoma

(2009) Kumiko Nakazawa et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Bladder Cancer Detection Using FISH (UroVysion Assay)

(2008) Kevin C. Halling et al.   ADVANCES IN ANATOMIC PATHOLOGY

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ

(2008) Ming Yin et al.   HUMAN PATHOLOGY

Prospective Evaluation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder

(2008) Yair Lotan et al.   JOURNAL OF UROLOGY

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

(2008) Carvell T. Nguyen et al.   UROLOGY